{{Rsnum
|rsid=308447
|Chromosome=4
|position=122817391
|Orientation=plus
|GMAF=0.3976
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 40.2 | 44.6 | 15.2
| HCB | 83.6 | 16.4 | 0.0
| JPT | 74.3 | 24.8 | 0.9
| YRI | 2.0 | 32.7 | 65.3
| ASW | 5.3 | 35.1 | 59.6
| CHB | 83.6 | 16.4 | 0.0
| CHD | 80.2 | 19.8 | 0.0
| GIH | 38.6 | 43.6 | 17.8
| LWK | 1.8 | 26.6 | 71.6
| MEX | 30.9 | 49.1 | 20.0
| MKK | 8.3 | 33.3 | 58.3
| TSI | 28.0 | 58.0 | 14.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19586755
|Title=Effect of basic fibroblast growth factor (FGF2) gene polymorphisms on SSRIs treatment response and side effects
}}

{{PMID Auto
|PMID=19456219
|Title=Polymorphisms in the FGF2 gene and risk of serous ovarian cancer: results from the ovarian cancer association consortium
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}